SUZHOU, China and MÖLNDAL, Sweden, March 20, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ('Ribo' or 'the Company ...
The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for ...
Researchers identify the hippocampus and microglia as the "tipping point" that determines if chronic pain leads to depression ...
New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.
Achieve optimal heating with Cubic's intelligent combustion control for condensing boilers, featuring advanced sensors for ...
Implementing strategies that slash laser diode failure rates by at least two orders of magnitude can banish ...
Welcome to Brii Bio's 2025 Full Year Financial Results and Corporate Update Conference Call. Our annual result announcements can be found on the Investor Relations section of our company website.
Highlights strategic progress achieved under Abizer Gaslightwala’s leadership, including advancement of AKTX-101 and ...
Phase 1 dose-escalation advancing as planned, targeting SMARCA4 (BRG1)-mutant cancers with a focus on non-small cell lung ...
SUZHOU, China and MÖLNDAL, Sweden, March 20, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ("Ribo" or "the Company", Hong Kong Stock Exchange code: 6938) had been invited to give ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results